CRO BioPharma Services acquires BLS assets, expands analytical services

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Alexander Traksel)
(Image: iStock/Alexander Traksel)

Related tags: Clinical trial

BioPharma Services has acquired intellectual property and human resource assets from Bioanalytical Laboratory Services (BLS), including a list of validated assays.

According to the contract research organization (CRO), BLS, also a CRO, has been building a bioanalytical research center specializing in complex method development, method validation, and biological sample analysis for pre-clinical and clinical drug trials (BA/BE studies), over the past three years.

The center was led by Lab Director, Nicola Hughes, Ph.D, who will now serve on BioPharma’s Executive Team as the Vice-President of Lab Operations.

Through the acquisition, BLS assets will be combined with BioPharma’s existing Bioanalytical Lab – further expanding the company’s analytical services.

Renzo DiCarlo, BioPharma Services CEO commented that under Hughes’ leadership, the expanded lab will “immediately offer challenging and complex new assays​,” which he said is just one of many benefits associated with the labs merging assets.

Any current BLS client projects will be completed as planned at the existing BLS facility.

Related news

Show more

Related products

show more

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us

Products

View more

Webinars